State Key Laboratory of Cell Differentiation and Regulation, College of Life Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, China.
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, Shanghai, China.
Front Immunol. 2024 Jul 30;15:1425384. doi: 10.3389/fimmu.2024.1425384. eCollection 2024.
Schistosomiasis is a zoonotic parasitic disorder induced by the infestation of schistosomes, a genus of trematodes. MicroRNAs (miRNAs) in egg-derived exosomes are crucial for modulating the host's immune responses and orchestrating the pathophysiological mechanisms. Although the exosomes secreted by contain abundant miRNAs, the specific roles of these miRNAs in the pathogenesis of schistosomiasis-induced hepatic fibrosis are yet to be comprehensively elucidated. The egg exosomes of secrete miRNA-30, a novel miRNA.
, the effect of miRNA-30 was evaluated by transfecting HSCs with miRNA mimics. The target gene biosignature for miRNA-30 was predicted using the miRDB software. The effect of miRNA-30 in hepatic fibrosis was evaluated by either elevating its expression in healthy mice or by inhibiting its activity in infected mice by administration of recombinant adeno-associated virus serotype eight vectors expressing miRNA-30 or miRNA sponges.
This novel miRNA can activate hepatic stellate cells (HSCs), the prinary effector cells of hepatic fibrosis, , i.e., it significantly increases the fibrogenic factors (), (), and at both mRNA and protein levels. In addition, miRNA-30 may activate HSCs by targeting the host RORA gene. In addition, experiments were conducted by administering a recombinant adeno-associated viral vector to modulate the expression levels of miRNA-30. The overexpression of miRNA-30 in healthy mice significantly elevated the expression of (), (), and -SMA at both the transcriptomic and proteomic scales. This overexpression was coupled with a pronounced augmentation in the hepatic hydroxyproline content. Conversely, the silencing of miRNA-30 in infected mice induced a considerable reduction in the size of hepatic granulomas and areas of collagen deposition. Hence, , modulation of miRNA-30 expression may play a pivotal role in ameliorating the severity of hepatic fibrosis in mice afflicted with .
The study results suggest that miRNA-30 may augment schistosomiasis-induced hepatic fibrosis through a probable interaction with the host RORA. Our study may improve the current theoretical framework regarding cross-species regulation by miRNAs of hepatic fibrosis in schistosomiasis.
血吸虫病是一种由血吸虫属吸虫感染引起的人畜共患寄生虫病。卵衍生外泌体中的 microRNAs(miRNAs)对于调节宿主的免疫反应和协调生理病理机制至关重要。虽然 分泌的外泌体含有丰富的 miRNAs,但这些 miRNAs 在血吸虫病引起的肝纤维化发病机制中的具体作用尚未得到全面阐明。 卵外泌体分泌 miRNA-30,一种新的 miRNA。
通过转染 miRNA 模拟物来评估 miRNA-30 的作用。使用 miRDB 软件预测 miRNA-30 的靶基因生物标志物。通过在健康小鼠中升高其表达或通过给予表达 miRNA-30 的重组腺相关病毒血清型八载体或 miRNA 海绵来抑制感染小鼠中其活性,来评估 miRNA-30 在肝纤维化中的作用。
这种新型 miRNA 可以激活肝星状细胞(HSCs),即肝纤维化的主要效应细胞,从而导致肝纤维化。具体而言,它在 mRNA 和蛋白质水平上显著增加纤维化因子()、()和 。此外,miRNA-30 可能通过靶向宿主 RORA 基因来激活 HSCs。此外,通过给予重组腺相关病毒载体来调节 miRNA-30 的表达水平进行了实验。在健康小鼠中过表达 miRNA-30 显著上调了转录组和蛋白质组水平上的 、()和 -SMA 的表达。这种过表达伴随着肝羟脯氨酸含量的明显增加。相反,在感染小鼠中沉默 miRNA-30 会导致肝肉芽肿的大小和胶原沉积面积显著减少。因此,调节 miRNA-30 的表达可能在改善感染小鼠肝纤维化的严重程度方面发挥关键作用。
研究结果表明,miRNA-30 可能通过与宿主 RORA 的可能相互作用来增强血吸虫病引起的肝纤维化。我们的研究可能会改善当前关于 miRNA 在血吸虫病肝纤维化中跨物种调节的理论框架。